News

News
Partner news

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story
Partner news

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story
Partner news

TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation

Read full story
Partner news

i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules

Read full story
Partner news

SRI International announces collaboration agreement with Janssen

Read full story
Partner news

Genocea Biosciences Provides Corporate Update

Read full story
Other news

ViaCyte Appoints Michael Yang President and CEO and Provides Company Update

Read full story
Other news

Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Other news

4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic

Read full story
Other news

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Read full story
Partner news

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Read full story
Partner news

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Read full story
Partner news

BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders

Read full story
Partner news

Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen

Read full story